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ABSTRACT 
 
Sarah Kay Youny Lee: Oral microbiome changes associated with fixed dental prosthodontic 
restoration 
(Under the direction of Kimon Divaris) 
 
The oral microbiome is a relatively unexplored component of oral health and disease. 
Common oral diseases, including dental caries and periodontitis, are now best understood as 
dysbiotic shifts of the oral microbial ecology. Prosthodontics is a cornerstone of clinical 
dentistry, serving to promote oral health through dental rehabilitation. However, it remains 
unknown if and to what degree prosthodontic treatment confers changes in the oral microbiome. 
In this observational clinical study, we studied the effects of fixed dental prosthodontic 
restorative treatment on the oral microbiome composition. Prosthodontic patients’ salivary 
samples were collected during their treatment course. Microbiome analyses relied upon whole 
genome sequencing (WGS) shotgun. Reads were aligned, mapped and analyzed to obtain 
measures relative abundance and diversity, as well as group and time differences. Results to-date 
have provided novel insights into oral microbiome changes during prosthodontic treatment that 
may characterize global transitions of clinical oral disease states to health. 
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INTRODUCTION 
 
1. Oral microbial communities and their organization 
 
The oral cavity is a dynamic environment built by communities of microbial cells 
consisting of bacteria, fungi, archaea, viruses, and protozoa (Wade 2013; Zaura et al. 2014). It is 
one of several interrelated systems of the body, including the gut, skin, and rectum, that make up 
the overall human microbiome and metagenome(Group et al. 2009; Human Microbiome Project 
2012b). The cells of these microbiomes account for 90% of cells of the human body (Savage 
1977; Wilson 2008). To explore this crucial capacity, relatively recent and extensive 
investigations have been done to better understand the oral microbiome organization of the oral 
cavity and its many parts in health and disease.  
 
1.1. Defining the oral microbiome 
 
The oral cavity is an ecosystem containing various habitats that consist of communities of 
commensal, symbiotic, and pathogenic microorganisms (Lederberg and McCray 2001). These 
communities are referred to as microbiomes (Ursell et al. 2012). 
Seven major phyla of bacteria dominate the oral microbiome: Firmicutes, Proteobacteria 
Actinobacteria, Bacteroidetes, candidate division TM7, Spirochaetes, and Fusobacteria 
(Dewhirst et al. 2010; Lazarevic et al. 2010; Wade 2013). These species have been found to vary 
within site-specific communities of the oral cavity - specifically supragingival dental plaque, 
saliva, and mucosa (Xu et al. 2015). The sites differ in their species composition and relative 
abundance (Dewhirst et al. 2010; Xu et al. 2015; Zarco et al. 2012; Zaura et al. 2014). Further, 
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significant variations are also observed with age and the stage of dentition, suggesting that the 
composition of the oral microbiome has a temporal component (Xu et al. 2015).  
The oral microbiome consists of a core set and variable set of microorganisms that are in 
a flux of symbiosis and dysbiosis based on innate and acquired host factors such as genetics and 
oral hygiene habits. The core microbiome is a patterned diversity displayed in clinically healthy 
oral environments and is consistently shared between different individuals. On the other hand, 
the variable microbiome consists of microbial communities unique to the individual (Bik et al. 
2010; Zarco et al. 2012; Zaura et al. 2014). 
 
1.2. Biofilms and the oral microbiome   
 
The oral bacteria are predominantly organized in biofilms within the oral cavity (Marsh 
2006; Socransky and Haffajee 2005). The physical integrity of the biofilm is based upon an 
exopolymer matrix structure that encapsulates a specific compositional and spatial design of 
microorganisms (Jenkinson and Lamont 2005; Sbordone and Bortolaia 2003). The microbial 
composition develops by way of inter-species interactions as well as interactions with the host 
environment and its subsequent reaction to the inhabiting microorganisms that leads to a process 
of succession (Bick et al. ; Sbordone and Bortolaia 2003; Socransky and Haffajee 2005). 
Quorum sensing, a bacterial mode of communication in which quorum sensing molecules are 
produced and detected by cells, has been suggested as one of the primary mechanisms by which 
a biofilm regulates the balance of healthy and pathogenic concentrations of microbial species 
(Wade 2010).  
Evidence shows that the relative abundance of bacteria within the oral microbiome is 
based on ecological location within the oral cavity and time - from the aspects of the maturation 
of a niche’s state of health or disease and age of the human host (Costalonga and Herzberg
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 2014).  These biotas are essentially biofilms that organize both spatially and 
temporally(Sbordone and Bortolaia 2003).  
1.3. Saliva and the oral microbiome 
 
Saliva is a biological fluid made of water, proteins, and inorganic and organic substances 
contained within the oral cavity. While the oral microbiome has specific ecological organization, 
the salivary microbiome has been shown to be representative of the overall oral microbiome due 
to its ability in collecting the shedding surfaces of these oral niches(Fabian et al. 2008; 
Yamashita and Takeshita 2017). It can serve as a global marker of the oral microbiome because 
of its encompassing nature in which saliva directly contacts and carries components derived from 
other oral structures such as gingival crevicular fluid, cell debris, plaque, nasal and bronchial 
secretions, lining cells, blood, exogenous substances, and bacteria(Curtis et al. 2011; Fabian et 
al. 2008; Fox 1989; Kaczor-Urbanowicz et al. 2017; Kaufman and Lamster 2000; 2002; Lee 
2009; Liu and Duan 2012; Mandel and Wotman 1976; Saliva: Its role in health and disease. 
Working group 10 of the commission on oral health, research and epidemiology (core)  1992). It 
contains mRNAs, proteins, and DNAs from local tissue as well as tissues from distant sites. 
 Even though bacterial species tend to be site-specific (Aas et al. 2005; Dewhirst et al. 
2010; Paster et al. 2006; Wade et al. 2005; Xu et al. 2015), previous evidence suggests that saliva 
houses bacteria, both aerobic and anaerobic, that characterize the state of other oral niches such 
as supragingival plaque and subgingival, periodontal pockets(Asikainen et al. 1991; Bowden 
1997; de Jong et al. 1984; Greenstein and Lamster 1997; Simon-Soro et al. 2013; Umeda et al. 
1998). Saliva does disproportionally consist of microbial cells deriving from the tongue’s 
biofilm, but it serves as a reservoir for shedding surfaces found in the oral cavity, usually from 
desquamating epithelial surfaces (Costalonga and Herzberg 2014; Simon-Soro et al. 2013). 
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Saliva has been shown to exhibit long-term temporal stability (Belstrom et al. 2016b; 
Rasiah et al. 2005; Stahringer et al. 2012; Yamanaka et al. 2012; Zhou et al. 2013) and affected 
by the host and host’s systemic condition (Lira-Junior et al. 2018; Zaura et al. 2017), but its 
composition has been found to be altered based on external factors such as use of systemic 
antibiotics, as well as chemo- and radiotherapies (Lazarevic et al. 2013; Xu et al. 2013). 
However, the salivary bacterial profile variance has been found to be comparable, at around 
13.5%, to variations found in distributions of genera in neutral genetic markers between 
individuals in human populations(Nasidze et al. 2009). This implies that saliva may be 
applicable in a global sense in which geographic location may not necessarily impart a distinct 
composition.  
As such, saliva can be used as a tool for assessment and diagnosis, as well as potential 
predictive indicator of oral microbial health status (Belstrøm 2016; Belstrom et al. 2016a; 
Kaczor-Urbanowicz et al. 2017; Kaufman and Lamster 2000; 2002; Lee 2009; Liu and Duan 
2012).  
1.4. Next generation sequencing (NGS)  
 
The process of characterizing the oral microbiome consists of a conglomeration of 
techniques. Traditional cultured isolates of bacteria have yielded approximately 280 identifiable 
species(Dewhirst et al. 2010). However, the majority of oral bacteria cannot be cultivated and 
thus are unobservable unless cultivation-independent molecular methods are used (Wu et al. 
2014). An early high-throughput technology that was based upon 16S ribosomal RNA gene 
sequencing was made possible because this microbial gene sequence is found in prokaryotes and 
demonstrates high variability that can be utilized in the identification of a broad spectrum of 
microbes(Ahn et al. 2011; Dewhirst et al. 2010). 16S rRNA pyrosequencing, Illumina 
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sequencing and the Human Oral Microbe Identification Microarray (HOMIM) have been used by 
several studies and were shown to be valid and efficient means of studying the oral 
microbiome(Ahn et al. 2011).The core data of the oral microbiome has been accumulated to 
form the Human Oral Microbiome Database, a collection of microbial reference genomes 
consisting of known species, unnamed isolates, and unnamed and uncultured phylotypes 
recognized by the 16S rRNA sequence information (Ahn et al. 2011; Dewhirst et al. 2010). This 
database organizes the defined human oral microbial taxa in a standardized manner that is 
accessible for research and dissemination(Ahn et al. 2011). It is also part of a greater 
conglomeration known as the Human Microbiome Project in which bacterial genome sequences 
are being collected in major ecological sites of the body – the nasal cavity, oral cavity, 
gastrointestinal tract, and urogenital tract (Ahn et al. 2011; Dewhirst et al. 2010; Morgan et al. 
2013). 
1.4.1. Whole genome sequencing (WGS) shotgun - metagenomics  
   
WGS, a type of NGS approach, sequences large quantities of DNA, ordering the 
nucleotides such that variations can be identified in any part of the genome (Bick et al. ; 
Genomic research  2018; Human Microbiome Project 2012a; Ng and Kirkness 2010; Weinstock 
2012).  It taxonomically profiles a microbial community to the species, and more detailed, the 
strain level (Weinstock 2012). WGS also enables functional profiling of metagenomic and 
metatranscriptomic sequence data, including aggregated whole-community level pathway 
reconstruction (Abubucker et al. 2012; Fodor et al. 2012; Lozupone et al. 2006; Nyvad et al. 
2013; Schloss et al. 2009; Segata et al. 2013; Weinstock 2012). 
WGS can be employed using two methods: a reference-based assembly and de novo 
assembly (Ng and Kirkness 2010). With the reference-based assembly, short lengths of DNA 
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sequence (reads) are compared to an existing reference genome sequence such that a consensus 
sequence can be formed (Ng and Kirkness 2010). With de novo assembly, the total microbial 
DNA is directly sequenced through overlapping of comparable sequence reads that are 
overlapped to form long sequences (contigs) (Ng and Kirkness 2010; Nyvad et al. 2013; 
Weinstock 2012). The process of generation, assembly, organization and analysis of WGS data is 
complex, computationally, time and resource intensive, but can be highly informative (Bick et al. 
; Weinstock 2012).  
By utilizing WGS, a more comprehensive compositional view of microbial communities 
can be generated.  
2. Oral health and disease 
 
The oral microbiome is a highly individualized, dynamic composition of commensal 
microbial species with development and interactions influenced from host genetic and 
environmental factors (Costalonga and Herzberg 2014; Gomez et al. 2017; Wade 2010).  
 
2.1. Previous models of oral disease and bacteria 
 
The mechanisms of oral diseases such as caries and periodontitis have historically been 
understood as infectious microbial processes, in which disease-specific bacteria induce a 
negative impact on susceptible oral structures. This pathogenicity-driven model related disease 
occurrence to certain microorganisms that had the ability to overcome and/or surpass host 
defenses.  
2.1.1. Caries 
  
 The caries process was traditionally viewed as a bacteria-specific disease. Mutans 
streptococci (MS) and Lactobacillus acidophilus were identified as the key bacteria associated 
with caries (Hamada and Slade 1980; Liljemark and Bloomquist 1996; Loesche 1986; van Houte
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 et al. 1994). Theories that attempted to explain dental decay emerged and were organized into 
specific versus non-specific plaque hypotheses (Kleinberg 2002; Loesche 1986).  
Caries-pathogen acquisition was hypothesized to occur within a “window of infectivity”, 
in which colonization of MS occurs at the time of primary teeth eruption(Caufield et al. 1993). 
Furthermore, previous research then linked the source of vertical transmission from mother, or 
other closest caregiver, to child, describing infants with MS also had mothers and caregivers 
carrying this pathologic bacteria(Berkowitz 2006; Berkowitz et al. 1975). Horizontal 
transmission of MS, in which microorganisms are transferred between members of a group, had 
also been found to be plausible as children sharing a daycare setting and non-mother members in 
the immediate family have been found to share genotypes of MS(Mattos-Graner et al. 2001; van 
Loveren et al. 2000).   
2.1.2. Periodontal disease 
 
Periodontal diseases, ranging from gingivitis to aggressive periodontitis, were 
investigated based on species-association to a particular type of disease (Moore et al. 1983; 
Moore et al. 1982; Paul 1970; Slots 1979; Socransky Sigmund and Haffajee Anne 1994; 
Socransky and Haffajee 1992; Tanner et al. 1979). Microbes distinctive to a diseased state were 
identified as keystone pathogens and included Porphyromonas gingivalis, Tannerella forsythia 
(previously known as Bacteroides forsythus), and Actinobacillus actinomycetemcomitans (Moore 
and Moore Lillian 1994; Proceedings of the 1996 world workshop in periodontics. Lansdowne, 
virginia, july 13-17, 1996  1996; Socransky Sigmund and Haffajee Anne 1994). The concept of 
pathogenic bacterial complexes, particularly gram-negative varieties, then emerged, based on 
studies of microbial profiles derived from plaque samples that were analyzed via DNA probes in 
checkerboard hybridization assays, in which particular species were commonly found together 
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(Socransky Sigmund and Haffajee Anne 1994; Socransky and Haffajee 2005). The complexes 
were organized by a color-code system that indicated the microbial clustering, community 
ordination, and disease states as complexes and their pathogenic nature changed based on disease 
progression (Socransky and Haffajee 2005). The occurrence of periodontal disease was based on: 
1) virulence of a bacterial pathogen, 2) the local environment, and 3) host susceptibility 
(Haffajee and Socransky 1994).   
2.2. Current understanding of the oral microbiomes in health and disease 
 
It is now understood that the processes of health and disease, as well as their dynamic 
balance, are community-driven, rather than pathogen-specific(Adler et al. 2013; Cephas et al. 
2011; Ling et al. 2010; Sbordone and Bortolaia 2003; Xu et al. 2015). Microbial interactions, 
over a period of time and with influence from both physiologic host development and 
environmental factors such as dietary habits and hygiene, cause changes in the abundance and 
ergo, metabolism and expression of microorganisms within the oral environment (Bernard et al. 
2012; Costello et al. 2012; Sbordone and Bortolaia 2003). The resulting host-bacteria responses 
are then indicative of whether health is preserved or disease is elicited (Buskermolen et al. 2018; 
Cosseau et al. 2008; Costello et al. 2012; Krisanaprakornkit et al. 2000; Peyyala et al. 2012).  
Microbial biofilm shifts contribute to oral diseases (Dewhirst et al. 2010; Scannapieco 
2013; Zarco et al. 2012). Biofilms can be viewed as a subset of a microbiome and demonstrate 
specific microorganism organization, communication, and functions(Faveri et al. 2015; 
Hajishengallis and Lamont 2012; Lin 2017; Marsh 2004; 2006; Sbordone and Bortolaia 2003; 
Teles et al. 2012; Wang et al. 2014). More than 65% of bacterial infections are biofilm-related, 
and it is the multiple organisms within a biofilm that can maintain health or cause disease (Lewis 
2001). Common oral diseases such as caries and periodontitis are not simply pathogen-driven 
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conditions but rather clinical manifestations of dysbiosis occurring in the supragingival and 
subgingival oral microbiome, respectively (Jorth et al. 2014). In a state of symbiosis, the core 
and variable microbiomes interplay with their host and the host’s factors to promote and 
maintain health. When disrupted, dysbiosis occurs and thereby, the disease process proceeds.  
2.2.1. Caries 
 
Investigations to understand the differences presented in a microbiome of a caries-free 
versus caries-active person demonstrate the complexity of bacterial diversity and interactions 
within a temporal scheme. It is understood that in infancy, heritable bacteria within the oral 
microbiome have been found to not be associated with caries pathogenicity, but with time, have 
reduced abundance (Gomez et al. 2017). The biofilms associated with a homeostatic state of 
health become disrupted, causing an ecological change in which microbial species tolerating the 
unbalanced state, become more dominant, and by which, a compositional change is incurred 
((Marsh 2006; Nyvad et al. 2013; Takahashi and Nyvad 2011). Whereas, environmentally 
derived bacteria are more prevalent with age and more likely to cause caries (Gomez et al. 2017).  
Novel species and their relative abundance in non-carious and carious states have been 
further identified through culture-independent methods (Belstrom et al. 2017b; Yang et al. 2014; 
Yang et al. 2012). Even though a large abundance of MS and L. acidophilus has continued to 
correspond to the disease-associated microbiota, these species are also notably present in non-
diseased oral cavities or are absent in diseased states, suggesting that either these bacteria are 
part of the commensal environment of the microbiomes in the oral cavity, the proportion of the 
species and its functions may promote disease rather than presence alone being indicative of 
disease, or that a more specific strain of the species may contribute to the dysbiosis (Belstrom et 
al. 2017a; Belstrom et al. 2014; Belstrom et al. 2015; Belstrom et al. 2017b; Costalonga and 
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Herzberg 2014; Eriksson et al. 2017; Simon-Soro et al. 2018). Taxa likely associated with caries 
are impacted by environmental influences and show variation based on sucrose consumption and 
age (Costalonga and Herzberg 2014; Gomez et al. 2017). Bacterial functions can also be 
modified on the basis of the ecological changes that affect the environment, enabling different 
niches to form as the microorganisms adapt (Duran-Pinedo and Frias-Lopez 2015). Health-
associated taxa change over time and interestingly show less abundance with increased sucrose 
intake (Gomez et al. 2017).  
2.2.2. Periodontal disease 
 
 The distinctive presence and greater concentration of known disease-associated bacteria 
in periodontitis has been established. Further, a pattern of previously uncultured, but disease-
associated microbes has been identified. But, the process by which this particular community 
shift occurs and establishes itself remains unclear.  
 It has been suggested that periodontitis operates in an initiator-promoter like causal 
mechanism where the microorganism composition sets up the disease process and the host’s 
response facilitates disease expression (Teles et al. 2013). Periodontitis-associated biofilms not 
only have their own make-up of microbes, but also a distinctive metabolism and function that 
promotes virulence (Teles et al. 2013). In conjunction to this, the host immune-inflammatory 
response is triggered, which sets forth the destruction of tissue.  
 Viruses, including Epstein-Barra virus-1, human cytomegalovirus, and herpesviruses, 
have been detected in periodontal diseases (Saygun et al. 2008; Slots and Contreras 2001; 
Sugano et al. 2004). The viral etiology of disease, in the context of synergistic viral-bacterial 
infection, may exacerbate bacterial pathogenicity through enhancement of the virulence or 
depression the clearance of bacteria (Barton et al. 2007; Slots 2010). Viruses also have the 
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capacity to impair to immune or modulate immune response to periodontal disease (Lin et al. 
2008; Lin and Li 2009; Loenen et al. 2001; Mogensen and Paludan 2001; Slots 2009; Slots et al. 
2006).  
2.3. Oral health and general health 
 
The oral cavity is one of the key gateways of generalized health (Dewhirst et al. 2010; 
Oral health in america : A report of the surgeon general  2000). The oral cavity’s condition 
determines and reflects the state of an individual’s physiological, psychological, and social status 
of health (Antonoff 1975; Oral health in america : A report of the surgeon general  2000). 
Systemic diseases like diabetes, heart disease, and respiratory diseases have been found to be 
associated with poor oral health status and can both affect and be affected by oral health. 
Individuals displaying immune-incompetency are particularly susceptible to development of 
serious, systemically-involved complications from oral sources of infection (Oral health in 
america : A report of the surgeon general  2000).  
3. Prosthodontics and oral health 
 
Restoration of oral structures is a functional and esthetic necessity by way of addition of 
anatomy that is not present due to congenital or acquired means. These restorations require the 
integration of prosthetic, or artificial, components. Dental providers engage in this form of 
treatment, be it from direct restorations, such as direct and indirect tooth restorations like 
amalgam or composite resin fillings and crowns, or, on a larger scale, reconstruction of the jaw 
after trauma or disease.
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3.1. Defining dental prosthetic reconstruction 
 
For the restoration of dentitions, utilized prosthodontic restorations can reconstruct a 
single tooth or multiple teeth, and can amount to the entire mouth. The treatment goal is to 
promote structural integrity that is supportive of function, via mastication and phonetics, as well 
as socio-psychological interactions related to one’s appearance and the capability of completing 
functional tasks in a socially acceptable, unimpeded manner (Franks 1976; Rosenstiel et al. 
2016).  
3.1.1. Fixed dental prosthesis (FDP) 
 
The fixed dental prosthesis (FDP) is a restoration that is secured to a natural tooth or 
dental implant abutment(The glossary of prosthodontic terms  2005). A tooth-borne FDP, 
commonly referred to as a crown, encompasses the majority of a tooth in order to recreate the 
appearance and functions of the tooth it is restoring. The FDP can also replace missing dentition 
in its bridge form, by which two teeth, covered by a single FDP, abut and are connected to a 
single-tooth prosthesis (The glossary of prosthodontic terms  2005).   
3.2. Indications for dental reconstruction 
 
The need for treatment through dental prostheses may arise from compromised oral 
health. Edentulism, the state of missing dentition, continues to be a significant health issue 
(Cooper 2009; Felton 2009). It mostly occurs as a consequence of the most common oral 
diseases (caries and periodontal disease), which can lead to tooth morbidity and tooth loss if left 
untreated. Dental trauma and cancers of the head and neck area are additional, yet less common 
indications for dental reconstruction.  
The concept of the prosthetic rehabilitation emerged from notion that restoration of an 
individual’s occlusion would improve the state of the supporting structures and thereby, oral 
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health(Franks 1976; Goldman 1949; McLean 1978; Yanase and Le 2014). Occlusion is restored 
through such that normal and healthy function can occur. With improved function, it was 
observed that blood circulation is improved(Goldman 1949).  
3.3. Prosthodontic treatment impact on general health 
 
Studies have evaluated the outcomes of prosthodontic treatment on quality of life and 
general health. In general, patients who had undergone prosthetic treatment of any kind, 
including removable and fixed prostheses, reported a self-perceived improvement in their general 
health (Reissmann et al. 2011; Wickert et al. 2014).  
3.4. Biological considerations for tooth-borne FDP restorations 
 
Treatment with FDP involves diagnosis, planning, treatment, and maintenance. These 
steps in the process are aimed towards establishment of reconstruction of the dentition within a 
stable state of oral health, free of disease.  
The process of restoration requires the creation of a sound and intact tooth foundation. 
This necessitates the removal and management of disease (Rosenstiel et al. 2016; Zitzmann et al. 
2010). Though it has been reported that FDP restorations have an average lifespan of 10 years, 
complications that compromise the restoration or cause failure are anticipated (Tan et al. 2004). 
Caries, pulpal injury, and periodontal disease are the leading causes of biological 
complications in tooth-borne fixed prosthetic treatment(Goodacre et al. 2003; Pjetursson et al. 
2007; Pjetursson and Lang 2008; Tan et al. 2004; Yanase and Le 2014). This suggests that the 
longevity of a fixed prosthetic restoration is dependent on appropriate therapy of biologic factors 
that are attributable to and/or contribute to these complications. Placement of exogenous items in 
the oral cavity, (e.g., restorative materials and cements), likely impact the host its microbial 
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ecology. In return, these interactions can also affect the status of the prostheses and their long-
term success. 
While technical execution and fabrication of a quality prosthesis are important in the 
more immediate success and survival of a restoration and its tooth component, a favorable long 
term prognosis relies on the management of factors surrounding and outside of the parameters of 
the restoration (Antonoff 1975; Valderhaug 1980; Yanase and Le 2014).  
4. Statement of Purpose 
 
Prosthodontic dental treatment is the cornerstone of dental practice as it relates to the care 
and rehabilitation of a compromised dentition, usually due to the results of common oral 
diseases. However, it remains unknown if and to what degree prosthodontic treatment confers 
any (positive) changes in the oral microbiome. This study seeks to address this knowledge gap 
via the following aims: 
Aim 1. Evaluate the salivary oral microbiome composition and diversity using next-
generation sequencing (NGS) methods, arising from various clinical states of oral health (e.g., 
caries, periodontal disease, diabetes mellitus) as assessed in a cross-sectional manner. 
Aim 2. Determine the effects of fixed dental prosthodontic restorative treatment on the 
salivary oral microbiome composition and diversity, in a prospective manner.
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MATERIALS AND METHODS 
 
1. Study design 
 
This study was approved by the Institutional Review Board at UNC (UNC IRB #16-
0040) and followed the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) guidelines on reporting observational human research studies. Participants were 
recruited from the UNC Graduate Prosthodontics clinic in Chapel Hill, NC between November 
2016 and February 2018 and all provided written informed consent. 
The study was designed as an observational, prospective cohort study investigating 
changes in the oral microbiome associated with prosthodontic dental rehabilitation. 
Unstimulated, whole saliva samples were obtained before, during, and after the completion of 
prosthodontic treatment. The participants are asked to provide three salivary samples at pre-
defined time points within their treatment scope (pre-treatment, during, and post-treatment) using 
the OMNIgene ORAL OM-501 (DNA Genotek, OraSure Technologies, Canada) saliva 
collection kit.  
2. Patient selection 
 
Eligible study participants are UNC School of Dentistry patients who have been planned 
for, agreed to, and committed to undergo prosthodontics treatment with a graduate prosthodontic 
resident provider at the Graduate Prosthodontics clinic. The sample reported here comprises 17 
adult patients between the ages of 40-78 years old requiring at least six fixed dental prosthetic 
restorations. Medical and dental histories were obtained at the time of screening and initial 
sample collection. 
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2.1 Inclusion criteria 
 
Eligible participants must have met the following inclusion criteria: adult males or 
females who are years or older, able and willing to follow study procedures and instructions, able 
to read, understand and sign the consent form, in good general health, agree to undergo 
prosthodontic treatment consisting of, at minimum, definitive placement of six (6) units of any 
type of fixed dental prostheses (full coverage crowns or retainer crowns, pontics, inlays, onlays, 
implants). 
2.2. Exclusion Criteria 
 
Individuals are not be eligible for study participation if any of the following exclusion 
criteria apply: had a chronic disease with oral manifestations, exhibited gross oral pathology, 
received treatment with antibiotics for any medical or dental condition within 6 months prior to 
the screening examination, exhibited active periodontal disease, received chronic treatment (i.e., 
two weeks or more) with any medication known to affect periodontal status (e.g., phenytoin, 
calcium antagonists, cyclosporin, coumadin, non-steroidal anti-inflammatory drugs, aspirin) 
within 6 months of the screening examination, received ongoing medications initiated less than 6 
months prior to enrollment (i.e., medications for chronic medical conditions must be initiated at 
least 6 months prior to enrollment). 
2.2. Continuance criterion 
 
If in the duration of the study, any medical and/or dental status changes occur and apply 
to the exclusion criteria, the subject will be withdrawn. 
 
 
	 17  
3.  Data collection and analysis 
 
3.1. Electronic patient record (EPR) data 
 
Dental and medical records are accessed via the school of dentistry EPR system to 
confirm that participants fit within the study's inclusion criteria and to also derive demographic, 
medical history and dental treatment information for eligible participants. Each participant’s 
initial/presenting oral condition (e.g., clinical charting), based on the graduate provider’s clinical 
examination and the planned restorative reconstruction, is recorded. 
3.2. Clinical procedures 
 
The first salivary sample (pre-treatment salivary sample) is obtained at any visit prior to 
the initiation of fixed dental prosthetic treatment from the patient’s presenting restorative 
condition. The second sample is obtained at any appointment in which active oral disease have 
been managed but before placement of any definitive fixed dental prosthetic restorations (e.g., 
time of final impression). The third salivary sample is planned to be obtained one to two months 
after completion of the restorative reconstruction, during a post-operative follow-up examination 
treatment.  
4. Saliva sample collection 
 
The OMNIgene ORAL OM-501 (DNA Genotek, OraSure Technologies, Canada) saliva 
collection kit is used for all sample collections. The participants are instructed and verbally 
confirmed to not have had any solid or liquid oral intake for at least 30 minutes prior to saliva 
collection. Following the manufacturer’s instruction, unstimulated, whole saliva is collected 
from the patient via expectoration, under supervision of a trained study assistant for as long as it 
is necessary to collect the required amount (2mL) of saliva. 
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5. Sample preparation, nucleic acid extraction, WGS shotgun  
 
After total nucleic acid extraction from the saliva samples according to the manufacturers 
instructions, 1 ng of intact genomic DNA was processed using the Nextera XT DNA Sample 
Preparation Kit (Illumina, San Diego, CA). Next, tagmented DNA was amplified via a limited-
cycle PCR programme adding index 1(i7) and index 2(i5) (Illumina) in unique combination for 
each sample, as well as primer sequences required for cluster formation. Each library was 
purified using Agencourt® AMPure® XP Reagent (Beckman Coulter, Brea, CA) and quantified 
with Quant-iT™ PicoGreen® dsDNA Reagent (Molecular Probes, Thermo Fisher Scientific 
division, Waltham, MA). The resulting pool was heat denatured before loading on the HiSeq 
reagent cartridge and on the HiSeq 2500 instrument (Illumina). 150 base-pair paired-ended 
sequencing was carried out using a HiSeq SBS V4 (250 cycles) sequencing kit according to 
manufacturer´s instructions in the presence of 10% PhiX control (Divaris et al. In Press). 
6. Bioinformatics pipeline and statistical analyses  
 
Pair-ended sequencing reads were de-multiplexed and converted to FASTQ. Quality was 
assessed with FastQC. Reads were then aligned, human reads were removed, and all reads were 
converted to a single single-read dataset. Microbial community profiling was done using 
MetaPhlAn2.2. Further analyses were based on measures of relative abundance and diversity, 
measures relative abundance and diversity, selected species identification, as well as group and 
time differences in these metrics, using parametric (e.g., t test), non-parametric (e.g., Wald X2) 
tests and graphical means. These included principal component analyses, PCoA, Scree, NMDS 
and tSNE plots. Due to the exploratory nature and pilot character of the study, corrections for 
multiple testing were not applied (Divaris et al. In Press).
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RESULTS 
 
1. General data 
 
At the 1 year and 3 months since initiation of this investigation, 21 salivary samples were 
obtained from 17 subjects, with 4 subjects having had samples from 2 visits.  Baseline 
demographic data and clinical characteristics of the subjects are summarized in Table 1. 
  
Table 1. Demographic and clinical data 
 
A: Implant placement during treatment, B: Implant placement prior to treatment, AB: Implant 
placement prior to treatment and during treatment, NA: No implant placement  
 
 At baseline, samples were grouped based on caries status (absent versus present) for 
comparisons and distribution analyses.  
The average abundance of genes and pathways per sample, as normalized for sequencing 
depth and gene length, was assessed in RPK (Reads Per Kilobase) and presented in Figure 1. The 
gene abundance distribution of samples and path abundance distribution of samples were further 
transformed by taking the logarithm to the base of 2 (figure 2, figure 3).  
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1 Summary and screening
1.1 Sample distribution
There are 17 subjects including 4 subjects with 2 visits (21 observations in total). The
distribution of the phe otype is given in Tabl 1.1.1 and some of th joint distributions
are illustrated in Figure 1.1.1.
Table 1.1.1: Summary of the phenotypes
Variable No Yes NA Total
Caries 6 11 - 17
Perio 8 9 - 17
Gingivitis 4 13 - 17
Diabetes 5 12 - 17
second visit 13 4 - 17
Gender Female: 4, Male: 13 17
Smoker 0: 3, 1: 12, 2: 1, NA: 1 17
Implant A: 8, B: 1, AB: 5, NA: 3 17
Age Min 40, Med 67, Max 78 17
Figure 1.1.1: Graphical representation of joint distribution
Note that doing exploratory multiple testing with a small sample size following state-
ments may not be statistically generalizable.
• (Upper left plot) No salient association between dental caries vs. either age or
smoking status.
Younger people are more likely to smoke (linear model, p = 0.056).
2
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Figure 1. The average abundance of gene (in RPK) and pathways per sample at baseline 
 
 
Figure 2. Gene abundance distribution of each sample (in RPK) 
 
Zero counts excluded, Gray boxes represent 2nd visit 
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• (Upper right plot) Men are more likely to have dental caries.(Fisher test, p =
0.099, OR = 8.5 )
• (Bottom left plot) No association between caries and gingivitis, and between caries
and perio.
If perio = 1, then most likely gingivitis = 1. (Fisher test, p = 0.03, OR =1 )
• (Bottom right plot) Smokers with diabetes are likely to have dental caries. (But
logistic model gives a large p-value even with an interaction term because of the
single observation at smoker=2)
1.2 The average abundance of gene (in RPK) and pathways per
sample
Figure 1.2.1: The average abundance of gene (in RPK) and pathways per sample at baseline (the first
visit)
No subject has too small or too large mean RPK (genes) or mean path abundance,
and the abundance do not seem to be associated with the dental caries diagnosis.
The log2 abundance of individual gene families and pathways are presented in Fig-
ure 1.2.2. Zero counts are excluded and the gray boxes represent the second visits.
3
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Figure 1.2.2: The abundance of each gene (in RPK, top) and each pathway (bottom) per sample
4
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Figure 3. Pathway abundance distribution of each sample 
 
Zero counts excluded, Gray boxes represent 2nd visit 
 
No subject demonstrated an excessively small or large mean of RPK (genes) or mean 
path abundance. The abundance also did not demonstrate association with dental caries 
diagnosis.  
2. Salivary metagenome analysis: Species-level 
 
Metagenomic Phylogenic Analysis (MetaPhlAn2), a Maker Gene Based Taxonomic 
Assignment strategy was applied for identification of the microbial taxa from the salivary 
metagenome. The number of species, alpha, and beta diversities were studied(Whittaker 1972). 
For testing group mean differences, two-sample t-tests, or more generally Wald tests, were 
conducted based on linear models with the continuous covariates. Because this is an exploratory 
study, p-values were not routinely corrected for the multiple testing.  
To compare the similarity of composition of bacteria between samples, the dimension of the 
compositional data was reduced and possible clustering was assessed. For dimension reduction, 
the species were screened by detection rate of 0.002 and prevalence threshold of 0.5, and 
methods including Non-metric Multidimensional Scaling (NMDS) (Kruskal and Wish 1978), t-
March 2018
Figure 1.2.2: The abundance of each gene (in RPK, top) and each pathway (bottom) per sample
4
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Distributed Stochastic Neighbor Embedding (t-SNE) (van der Maaten et al. 2008), and Principal 
Component Analysis (PCoA) (Pearson 1901) were applied. For NMDS, Bray-Curtis dissimilarity 
index was used. For tSNE, Euclidean distance metric and perplexity of 5 were used. For PCoA, 
the proportion of variability added by additional dimensions was examined through the scree 
plot. 
Top abundant species were compared for each feature group by their rankings within the 
group. For the subjects with two longitudinal saliva samples, change in alpha diversity, and 
change in Principal Component (PC) values were studied (Whittaker 1972).  
2.1. Number of genera/species 
 
 From all samples, 81 genera and 214 species, based on 360,907 gene families and 298 
pathways, were identified. In comparing samples, no significant differences were noted in the 
number of species based on caries status (figure 4).  
 
Figure 4. Species in each group 
 
p-value (t-test) = 0.93 
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2 Ecosystem - WGS Met phlan2 at baseline
The analyses are based on baseline data unless otherwise mentioned.
The microbiome community with dental caries tend to be more diverse. But this
tendancy is somewhat confounded with the age (See Section 2.4) so may not be true
after adjusting for the age.
2.1 Number of genera/species
In total, there are 214 species and 81 genera in metaphlan2 data. (360,907 gene families,
298 pathways)
For each subject, the number of species is given in the figure below. There is not a
big di↵erence in number of species between caries groups.
p-value (t-test) = 0.93
2.2 Beta diversity of bacteria (species level)
p-value (t-test) = 0.61
5
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2.2. Abundance of bacterial species 
 
 The species-level abundance ranking of the samples was tabulated (table 2). Differential 
abundances were observed between caries and caries-free groups: Actinomyces sp HPA0247 and 
Actinomyces graevenitzii demonstrated greater mean abundance in carious samples, while 
Neisseria subflava had greater mean abundance in caries-free samples.   
 The NMDS plot revealed no significant distinction between samples based on the 
presence of caries (figure 5). The tSNE plot revealed lack of clustering, likely attributable to a 
small sample size (figure 6). The PCoA plot showed clustering of subjects with caries at the 
upper center portion of the plot, with the Scree plot demonstrating that 2-3 principal components 
contribute to total variance (figure 7). 
Table 2. Species-level abundance in salivary microbiome 
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Figure 5. NMDS plot of identified species 
 
 
Figure 6. tSNE scatter plot 
 
 
Figure 7. PCoA and Scree plots 
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3 Visualization
Visualization (PCoA, tSNE, PCA plot) is done for core microbiome (67 species out of
213 species)
3.1 Visualization - NMDS
The NMDS plot below is based on the metaphlan2 (species level). Not much distinction
between dental caries diagnosis.
3.2 Visualization - tSNE
The tSNE plot below is based on the metaphlan2 (species level). Hard to see clusters
with a small sample.
3.3 Visualization - PCA
Hard to see clusters with a small sample, but caries group seems to cluster around upper
center. (The scree plot on the right tells us that 2 or 3 principal components will su -
cient.)
8
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2.3. Alpha diversity and beta diversity  
 
At baseline, alpha and beta diversities, at the species level, were assessed.  
Alpha diversity, demonstrating species richness, through the number of taxa in the 
salivary microbiome, included Shannon diversity index (figure 8, figure 9), Simpson-Gini 
diversity index (figure 10), richness, and dominance. Richness was measured as the number of 
observed species within each sample given only top 50% or top 80% of the species (figure 12). 
Dominance represented the proportion of the abundance of the most abundant species (figure 
13).  
Beta diversity represented the differences of taxonomic abundance from different 
samples (figure 14). Beta diversity was measured using average Bray dissimilarity within each 
feature group.  
The salivary microbiome, as presented by the samples, showed a greater tendency for 
more diversity in caries-associated samples though there was not a significant difference in 
number of species between the samples. Specifically, older patients demonstrated less diversity, 
and with caries status, the diversity observed initially with caries is less clear (figure 9, figure 
11).  
Figure 8. Shannon diversity index at the species-level as mean and range in each group 
 
p-value (t-test) = 0.13 
March 2018
2.3 Alpha diversity of bacteria (species level)
A. Shannon entropy
p-value (t-test) = 0.13
B. Simpson diversity
p-value (t-test) = 0.15
C. Richness - species (50%/80%)
p-value (t-test) = 0.93, 0.34
D. Dominance
p-value (t-test) = 0.28
6
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Figure 9. Linear model of Shannon diversity index at the species-level and age 
 
p-value = 0.28 (caries), 0.07 (age) 
 
Figure 10. Simpson-Gini diversity index at the species-level as mean and range in each group 
 
p-value (t-test) = 0.15 
 
Figure 11. Linear model of Simpson-Gini diversity index at the species-level and age 
 
p-value = 0.28 (caries), 0.18 (age) 
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2.4 diversity by age
Contrary to the result in the Early Childhood Dental Caries study (ZOE), older subjects
have less diversity (more dominance).
A. Shannon entropy vs age
When age is considered, we see that among the older, microbiome systems with dental
caries have high entropy, and healthy ones low entropy, but not as much as clear as
we have seen earlier in this section.
linear model (outcome ⇠ caries + age): p-value = 0.28 (caries), 0.07 (age)
B. Simpson diversity vs age
Similar for Simpson diversity.
linear model (outcome ⇠ caries + age): p-value = 0.28 (caries), 0.18 (age)
7
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Figure 12. Richness index at the species-level (50%/80%) 
 
 
p-value (t-test) = 0.93, 0.34 
 
Figure 13. Dominance index at the species-level according to caries status 
 
p-value (t-test) = 0.28 
 
Figure 14. Sample dissimilarity as measured by beta diversity at species-level 
 
p-value (t-test) = 0.61 
 
2.4. Longitudinal analysis 
 
Longitudinal changes in the salivary microbiome for 4 subjects with 2 samples were 
evaluated for comparison (Table 3). 
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2 Ecosystem - WGS Metaphlan2 at baseline
The analyses are based on baseline data unless otherwise mentioned.
The microbiome community with dental caries tend to be more diverse. But this
tendancy is somewhat confounded with the age (See Section 2.4) so may not be true
after adjusting for the age.
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Between visits 1 and 2, the subjects had the following course: 
Subject 002 had undergone 9 months of treatment consisting of 18 natural tooth 
preparations for FDP, 3 implants placements, bone graft, crown lengthening, and 6 tooth 
extractions. The subject also had two, 1-week courses of antibiotic prophylaxis in conjunction to 
treatment during that time period (one course is 500mg Amoxicillin, 3 times a day, for 7 days).  
Subject 005 had undergone 9 months of treatment consisting of 7 natural tooth 
preparations for FDP, bone graft, and 1 tooth extraction.  
Subject 007 had undergone 8 months of treatment consisting of temporary placement of 
a maxillary removable complete denture, 5 natural tooth preparations for FDP, 4 implant 
placements, 4 definitive tooth-borne FDP placement. The subject also had a single, 5-day course 
of antibiotic prophylaxis in conjunction to treatment during that time period (500 mg 
Amoxicillin, 3 times a day, for 5 days).  
Subject 010 had undergone 2 months of treatment consisting of 16 natural tooth 
preparations.  
Within and between subject analyses were graphically assessed with spaghetti plots of 
number of species (figure 15), alpha diversity using the Shannon-Wiener entropy index (figure 
16), Simpson-Gini diversity index (figure 17), and dominance index (figure 18). The very small 
sample size limits our ability to make robust inferences, but we did note that diversity increased 
with treatment. Notably, subject 002 exhibited a different pattern compared to the other 3 
subjects discussed here. Specifically, there is a noticeable change in the Simpson-Gini diversity 
index and the species-level dominance index specific to subject 002 between the first and second 
visits/samples (figure 17, figure 18).  
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Table 3. Demographic and clinical data of subjects with 2 samples (visits) 
 
A: Implant placement during treatment, B: Implant placement prior to treatment, AB: Implant 
placement prior to treatment and after treatment 
 
Figure 15. Number of species between visits and subjects 
 
 
Figure 16. Shannon entropy index at the species-level between visits and subjects 
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6 Longitudinal analysis
Using the information from those who visited twice, we plot the trajectories of some of
the diversity measures, and we fit longitudinal models.
The phenotypes of the repeated subjects are tabulated in Table 6.0.1.
Table 6.0.1: Phenotypes of the subject with 2 visits
id caries perio gingivitis diabetes smoker age gender implants
002 0 0 1 0 1 75 m AB
005 1 1 1 1 1 70 m AB
007(IRB) 0 0 0 0 1 65 f A
010 1 1 1 0 0 72 m AB
6.1 Spaghetti plots
The signal is very weak with only four subjects. Overall, the diversity increased after
treatment.
24
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Figure 17. Simpson-Gini diversity index at the species-level between visits and subjects 
 
 
Figure 18. Dominance index at the species level between visits and subjects 
 
 
Figure 19. Change in PC between visits and subjects at the species-level 
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6.2 Change in Principal components
Figure 6.2.1 shows the change in the principal components from the first to the second
visit.
Figure 6.2.1: Change in PC
All 4 second visits have regressed to the center of the space. The subject number 2
has the biggest change in both PCs.
6.3 Testing the association of each species with dental caries
Longitudinal models are non-identifiable or non-estimable due to small number of repli-
cates.
Chen & Li method might have been used for longitudinal compositional data (logistic-
beta model), to see if there is any association with a specific bacteria species with the
dental caries status, but for most of the core bacteria species, they do not have zero
counts. So the test could not be done.
Also simpler model such as linear mixed e↵ect models can be considered. However, to
predict the random e↵ects, there should be more sample or replicates, than is now. This
test could not be done either.
26
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3. Salivary metagenome analysis: Variables 
 
Diversity indices were compared across clinical characteristics and other medical 
information or comorbidities such as dental caries diagnosis, gingivitis, periodontal disease 
history, diabetes, gender, and smoking status. Findings related to diabetes and periodontal 
disease history were notable. 
3.1. Diabetes analysis 
 
 We found that the salivary microbiome of patients with diabetes was more diverse 
compared to those without diabetes. Though the number of species did not show any important 
difference (figure 20), alpha and beta diversity indices were different between the groups (figures 
21-24). The NMDS, tSNE, and PCoA plots revealed a distinct clustering of samples associated 
with diabetes (figures 26-28). 
Figure 20. Species in each group (diabetes) 
 
p-value (t-test) = 0.93 
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ling for the age (See Section 2.4), but the beta diversity is the opposite: i.e. the people in
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For each subject, the number of species is given in the figure below. There is not a
big di↵erence in number of speci s between diabetes groups.
p-value (t-test) = 0.93
2.2 Beta diversity of bacteria (species level)
p-value (t-test) = 0.002
4
	  32  
Figure 21. Shannon diversity index at the species-level as mean and range in each group 
(diabetes) 
 
 
p-value (t-test) = 0.015 
 
Figure 22. Simpson-Gini diversity index at the species-level as mean and range in each group 
(diabetes) 
 
p-value (t-test) = 0.013 
 
Figure 23. Richness index at species-level (50%/80%) (diabetes) 
 
p-value (t-test) = 0.48, 0.04 
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Figure 24. Dominance index at the species-level as mean and range in each group 
 
p-value (t-test) = 0.013 
 
Figure 25. Sample dissimilarity as measured by beta diversity at the species-level (diabetes) 
 
p-value (t-test) = 0.002 
 
Figure 26. NMDS plot of identified species (diabetes) 
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3 Visualization
Visualization (PCoA, tSNE, PCA plot) is done for core microbiome (67 species out of
213 species)
3.1 Visualization - NMDS
The NMDS plot below is based on the metaphlan2 (species level). Diabetes group is
clustered at center.
3.2 Visualization - tSNE
The tSNE plot shows similar result as in NMDS.
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Figure 27. tSNE scatter plot (diabetes) 
 
 
Figure 28. PCoA plot for each subject (diabetes) 
 
 
3.2. Periodontal disease history analysis 
 
 The salivary microbiome of patients with a previous history of periodontal disease was 
more diverse compared to those without history of periodontal disease. However, beta diversity 
analysis between groups of patients who had a history of disease versus no disease revealed the 
opposite (figure 34), signifying that diversity was similar between samples derived from 
previous history of periodontal disease than that of samples without a history of disease. The 
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number of species did not show any important difference (figure 29), whereas alpha and beta 
diversity indices differed between the groups (figures 30-34). 
The PCoA plot (figure 37) revealed a distinct clustering of samples associated with 
disease, but NMDS and tSNE, did not reveal any notable patterns (figure 35, figure 36). 
Figure 29. Species in each group (periodontal disease) 
 
p-value (t-test) = 0.49 
 
Figure 30. Shannon diversity index at the species-level as mean and range in each group 
(periodontal disease) 
 
p-value (t-test) = 0.021 
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Figure 31. Simpson-Gini diversity index at the species-level as mean and range in each group 
(periodontal disease) 
 
p-value (t-test) = 0.06 
 
Figure 32. Richness index at the species-level (50%/80%) (periodontal disease) 
 
p-value (t-test) = 0.49, 0.004 
 
Figure 33. Dominance index at the species-level as mean and range in each group (periodontal 
disease) 
 
p-value (t-test) = 0.011 
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Figure 34. Sample dissimilarity as measured by beta diversity at species-level (periodontal 
disease) 
 
p-value (t-test) = 0.14 
 
 
Figure 35. NMDS plot of identified species (periodontal disease) 
 
 
Figure 36. tSNE scatter plot (periodontal disease) 
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Figure 37. PCoA plot for each subject (periodontal disease) 
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3.3 Visualization - PCA
For the PCA plot, perio group is centered.
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DISCUSSION 
 
Full mouth rehabilitation treatment is geared towards achieving health. But, thus far, oral 
health has been assessed using clinical parameters that indicate preservation of tissues and 
structures without the presence of loss or destruction due to disease and/or parafunction. A dental 
provider evaluates objective criteria that measure for health versus disease in a subjective 
manner. So even though clinical health can be readily assessed, little research has been 
conducted in understanding how prosthodontic treatment may impact the oral microbial status 
within the contemporary understanding of oral health and disease as complex, host-biofilm 
dysbiotic states. In an effort to improve the state of oral health, understanding how these types of 
restorations may affect the foundation, one’s oral microbiome, may impart some insight on the 
efficaciousness of this approach in treatment. 
This study collected unstimulated, whole saliva samples. The choices regarding the type 
of saliva and method of collection were based on the sampling kit utilized for the study. 
However, in understanding the quality of gathered information, it is important to note that 
different studies have had varying findings in comparing the sensitivity and comparability of 
bacteria detected within stimulated versus unstimulated saliva(Schafer et al. 2014; Simon-Soro et 
al. 2013; Yakob et al. 2014). When using culture-based methods, stimulated saliva produced 
better detection of specific oral bacteria(Asikainen et al. 1991; Dasanayake et al. 1995), while 
pyrosequencing found stimulated saliva to be more diluted(Simon-Soro et al. 2013). A recent 
study systematically compared the salivary microbiota of within-subject samples obtained in 
both stimulated and unstimulated forms, using Human Oral Microbe Identification using Next 
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Generation Sequencing  (HOMINGS)(Belstrom et al. 2016a). It determined that no 
significant differences in composition and proportions of the respective bacterial profiles at the 
species and genus level probe targets(Belstrom et al. 2016a).  
This study’s salivary metagenomics analysis approach based on whole genome 
sequencing (WGS) shotgun allowed us to obtain a more comprehensive view of the oral 
microbiome. WGS can reveal more unidentified and unassigned, non-human taxonomic 
sequences of the salivary metagenome (Lazarevic et al. 2012); it can, thereby contribute to more 
information regarding the actual functional potential of the microbial cells through assignments 
of sequences from databases organized by functional sequences(Gerlach and Stoye 2011; Meyer 
et al. 2008). 
Previous studies have shown that salivary bacterial profiles differ between disease and 
non-disease statuses (Belstrom et al. 2017b; Chen et al. 2018). Differences in the abundance of 
particular species, namely of the genera of Neisseria, Haemophilus, and Fusobacterium, were 
evident when comparing compositions of microbiomes that had no active disease but a history of 
previous disease to those without any history of disease (Belstrom et al. 2017b). Bacterial 
diversity was found to be significantly higher in individuals with low caries experience than 
those with 10 times higher caries experience (Belstrom et al. 2017b). Similar findings have been 
observed for periodontal disease, in which bacteria that have known associations to disease 
continue to have proportionally large abundance and representation in diseased states(Ai et al. 
2017; Belstrom et al. 2015). 
Age, diabetes, and periodontal status appeared to also be associated with differences in 
the salivary microbiome in this study. Age has been found to affect the microbiome’s 
composition, though age in of itself may not necessarily cause change but rather an individual’s
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 health condition and associated co-morbidities such as increased presence of inflammatory 
markers that occur in older populations (Costalonga and Herzberg 2014; Lira-Junior et al. 2018; 
Nassar et al. 2014; Takeshita et al. 2016; Xu et al. 2015). Diabetes has not consistently been 
shown to alter the oral microbiome, though observed changes have been associated with co-
morbidities such as obesity. (Goodson et al. 2017; Janem et al. 2017; Kampoo et al. 2014).  
When evaluating changes incurred after therapy to treat a disease and restore health, 
studies have found that clinically determined improvements in oral conditions cannot be 
necessarily defined or quantified by bacterial abundance (Schwarzberg et al. 2014). Specifically, 
the notion of microbiologically diagnosing health based upon proportions of particular 
microorganisms associated with health and disease is not generalizable. Rather, compositions of 
microbial cells that promote symbiosis are unique to an individual’s specific microbiome and its 
functions and interactions (Schwarzberg et al. 2014). In periodontal disease therapy, diseased 
and previously-diseased oral environments were diverse and individualized, while microbiomes 
without a history of disease were homogenous(Chen et al. 2018).  
Longstanding treatment outcomes are ultimately not determined by prosthetic restoration, 
but by the ability to manage the microbial balance that is supportive towards health (Yanase and 
Le 2014). Management of an individual’s oral microbiome through behavioral and 
environmental modifications may, in fact, be the key for effective prevention and treatment 
(Gomez et al. 2017). The insertion of dental biomaterials, like crowns and implants, within the 
oral cavity also impacts the microbial community’s interactions. Each type of dental prosthesis 
has its own requirements for clinical application and laboratory fabrication (Rosenstiel et al. 
2016). The FDP, in particular, has an array of material types and an array of designs that have 
specific parameters for placement on a tooth (Goodacre et al. 2001). Furthermore, when the 
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foundational tooth is compromised, be it structural deficiencies, presence of disease on hard 
and/or soft tissues, or previous restorations (direct restorations like amalgam and composite resin 
restoration, root canal therapy, posts or pins), rendering treatment with FDP is more complex 
(Rosenstiel et al. 2016; Zitzmann et al. 2010). These restorations create new habitats by nature of 
the type, composition, and structure of the prosthesis (Lin 2017; Øilo and Bakken 2015). These 
habitats are being formed within an already established habitat of the tooth and gingival tissues, 
and thus the niches that microorganisms had previously had can potentially be altered.   
This present study has several limitations. Because it does not involve direct intervention, 
the prosthodontics treatment is non-standardized and dental providers’ sequence of care is left to 
their discretion. Therefore, timing between sample collection varied while some patients may 
had received definitive restorations and provisional restorations versus only provisional 
restorations. Another source of heterogeneity is the large number of covariates and comorbidities 
involved (e.g., age, systemic health, behaviors, medications, to name a few). The basic inclusion 
factor being 6 fixed, tooth-borne dental prosthesis enabled various types of treatment to be 
accepted within the study design, including implant therapy and removable dental prostheses. 
While these factors introduce some variance, they also reflect ‘real life’ in the sense that dental 
treatment is rarely standardized and individual patients present with their own set of individual 
variation and comorbidities. Another major limitation is obviously the small sample size; this 
reduces the statistical power and the study’s potential to make robust inferences and detect 
associations. Also, due to pilot and exploratory nature of the study, the findings may not be 
generalizable. However, the study protocol intends to recruit 30 participants (90 total samples), 
enhancing the study’s ability to make formal within- and between-subjects comparisons and 
inferences.
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Through the study of the oral microbiome, insight and improvements in preventive and 
interventional clinical practices can be made. Manipulation of the oral biofilm and its 
interactions may lead to more effective treatments. Likewise, distinguishing how the oral 
microbiome is altered and reacts in different states of health and disease may support the 
establishment of preventive measures such that disease can be prevented or minimized. The 
developing findings have led to the growth of the field of microbiomics – the therapeutic 
translation of microbiotic information to personalized health care (Glurich et al. 2015; 
Scannapieco 2013; Zarco et al. 2012). 
Caries prevention is being investigated through active and passive means of 
immunization. Both approaches entail the targeting of specific gateway pathogens like MS. For 
active immunization, particular components involved in interactions such as bacterial adhesion, 
glucan development or binding, and cell wall synthesis, can serve as immunogenic targets to 
illicit antibody formation and delivered through vaccination (Costalonga and Herzberg 2014). 
The passive means of acquiring immunity have been explored with antibody administration 
through routes like dietary supplements and dental trays. 
 In spite of the significant strides towards understanding the oral cavity and its 
microbiomes, limitations persist. Most of the data available pertain to bacterial species and do 
not characterize or delve into other facets of the oral environment such as fungal species 
(mycobiome) and viruses (viriomes) (Zaura et al. 2014). Additionally, profiling the genomic 
composition of a microbiome does not fully explain the functions provided by the 
microorganisms found within it. Meta-transcriptomics, proteomics, and metabolomics can 
further explain the process by which symbiosis is maintained or dysbiosis persists, by 
examination of the biological functions and metabolic activity of the microbial communities
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(Bao et al. 2015; Belstrom et al. 2017a; Duran-Pinedo et al. 2014; Duran-Pinedo and Frias-Lopez 
2015; Fabian et al. 2008; Xu and Gunsolley 2014).  
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CONCLUSION 
 
 The impact of the oral cavity and its health is important to general health and quality of 
life. With the progress of novel sequencing technologies and techniques, insights into the oral 
cavity and its constituents can be gained. This more expansive knowledge set can provide 
significant means for understanding the biological basis of health and disease of the oral 
environment. This is especially critical for dental providers who are invested in restoring the 
dentition and promotion oral health, as common diseases of caries and periodontitis continue to 
pose clinical problems and compromise restorations. Through this exploratory study, a pattern of 
change during prosthodontic treatment was evident, although the intricacies of what and why the 
salivary microbiome changes have yet to be fully assessed. The ultimate findings, however, can 
contribute to the growing field of microbiomics in which intentional manipulation of 
microorganisms and their functions and activities may be applied to develop and render more 
effective treatments.  
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